 Insulin Detemir
"Insulin Detemir" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.
| Descriptor ID |
D000069057
|
| MeSH Number(s) |
D06.472.699.587.200.300.050 D12.644.548.586.200.300.050
|
| Concept/Terms |
Insulin Detemir- Insulin Detemir
- Detemir, Insulin
- Basal Insulin Detemir
- Detemir, Basal Insulin
- Insulin Detemir, Basal
B29-tetradecanoyl-Lys-B30-des-Ala-insulin- B29-tetradecanoyl-Lys-B30-des-Ala-insulin
- B29 tetradecanoyl Lys B30 des Ala insulin
- Insulin, Tetradecanoyl-Lys(B29)-des-Ala(B30)
- 12C-Lys(B29)-DB30I
- Des-(B30)-insulin, Lys(B29)-tetradecanoyl
- Insulin, Tetradecanoyllysyl(B29)-desalanyl(B30)
|
Below are MeSH descriptors whose meaning is more general than "Insulin Detemir".
Below are MeSH descriptors whose meaning is more specific than "Insulin Detemir".
This graph shows the total number of publications written about "Insulin Detemir" by people in this website by year, and whether "Insulin Detemir" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 | | 2008 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Insulin Detemir" by people in Profiles.
-
Ji L, Zhang P, Zhu D, Lu J, Guo X, Wu Y, Li X, Ji J, Jia W, Yang W, Zou D, Zhou Z, Gao Y, Garg SK, Pan C, Weng J, Paul SK. Comparative effectiveness and safety of different basal insulins in a real-world setting. Diabetes Obes Metab. 2017 08; 19(8):1116-1126.
-
Nguyen KV, Weidner JA, Shaw KF, Valdez CA. Converting U-500 regular insulin to insulin detemir and insulin lispro in a patient undergoing dietary changes in preparation for bariatric surgery. Am J Health Syst Pharm. 2016 Mar 01; 73(5):292-7.
-
Shah VN, Moser EG, Blau A, Dhingra M, Garg SK. The future of basal insulin. Diabetes Technol Ther. 2013 Sep; 15(9):727-32.
-
Garg SK. The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes--a comprehensive review. Diabetes Technol Ther. 2010 Jan; 12(1):11-24.
-
Garg SK, Naik RG. Long-acting insulin analogs versus human insulins. Diabetes Technol Ther. 2008 Oct; 10(5):331-2.
-
Garg SK. New insulin analogues. Diabetes Technol Ther. 2005 Oct; 7(5):813-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|